🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Trial Title: FiTNEss (UK-MRA Myeloma XIV) - Frailty-adjusted therapy in Tr...
Status
Unknown
Location
Aberdeen Royal Infirmary
Start Date
2020-08-04
Trial ID
NCT03720041
The participants of this study would have relapsed/refractory follicular ly...
Status
Active Not Recruiting
Location
Southern Cancer Center
Start Date
2020-06-11
Trial ID
NCT04224493
Treatments Being Tested
The purpose of this study is to determine whether lenalidomide is safe and ...
Status
Completed
Location
Hematology Oncology Clinics of Australia, Level 5, Mater Medical Centre
Start Date
2007-01
Trial ID
NCT00405756
This study is designed as a phase III, randomized, double-blind, placebo-co...
Status
Completed
Location
Bendigo Hospital
Start Date
2009-04
Trial ID
NCT01122472
Treatments Being Tested
CLLM1 is a phase 3, multicenter, randomized, double-blind, placebo-controll...
Status
Completed
Location
University Hospital Cologne
Start Date
2012-07-20
Trial ID
NCT01556776
Treatments Being Tested
A study to evaluate the efficacy of lenalidomide as maintenance therapy aft...
Status
Terminated
Location
Sharp Healthcare Oncology Associates of San Diego
Start Date
2010-04-01
Trial ID
NCT01021423
Treatments Being Tested
This randomized phase III trial studies lenalidomide to see how well it wor...
Status
Active Not Recruiting
Location
Mayo Clinic in Arizona
Start Date
2004-12-15
Trial ID
NCT00114101
Immunoglobulin G4-related disease (IgG4-RD) is a chronic immune-mediated di...
Status
Not Yet Recruiting
Location
The First Medical Center of Chinese PLA General Hospital
Start Date
2026-08-01
Trial ID
NCT07719543
Treatments Being Tested
The purpose of this study is to determine if lenalidomide (Revlimid®) is sa...
Status
Completed
Location
Mayo Clinic - Arizona
Start Date
2009-01-27
Trial ID
NCT00774345
Treatments Being Tested